Sight Sciences, Inc. Common Stock SGHT
Analyst Ratings
- Consensus
- Moderate Buy — 5 Buy · 2 Hold · 0 Sell (7 analysts)
- Avg. Price Target
- $9.86 (+9.2% upside)
Key Stats
- Today's Range
- $8.91 – $9.11
- 50-Day Range
- $7.70 – $9.71
- 52-Week Range
- $3.19 – $9.71
- Volume
- 266K shs
- Average Volume
- 324K shs
- Market Cap
- $496.89 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.44%
- Days to Cover
- 1.00
About Sight Sciences, Inc. Common Stock
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Related Stocks
Compare head-to-head: SGHT vs SYK·SGHT vs BSX·SGHT vs RMD·SGHT vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.